PHIO

#5181
Phio Pharmaceuticals Corp. - Common Stock
0.0 1 USD
-99.03%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
0.01
0.01
Faixa anual
0.01
1.35
Mudança diária
-99.03%
Mudança mensal
-99.08%
Mudança em 6 meses
-99.07%
Mudança anual
-99.07%
Fechamento anterior
1.1 4
Open
0.0 1
Mínimo
0.0 1
High
0.0 1
Volume
5
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

Notícias